{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:36:36Z","timestamp":1740141396097,"version":"3.37.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21974045","82102503"],"award-info":[{"award-number":["21974045","82102503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National Key R&D Program of China","award":["2021YFF0701900"],"award-info":[{"award-number":["2021YFF0701900"]}]},{"name":"the Science and Technology Commission of Shanghai Municipality","award":["19142201100","6142200500"],"award-info":[{"award-number":["19142201100","6142200500"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["JKJ01221718"],"award-info":[{"award-number":["JKJ01221718"]}]},{"name":"Zhongshan Hospital Fudan University Youth Foundation","award":["2020ZSQN30"],"award-info":[{"award-number":["2020ZSQN30"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ANAL. SCI."],"DOI":"10.1007\/s44211-022-00238-9","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T19:03:08Z","timestamp":1672081388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Selective profiling of liver-related specific proteins based on sofosbuvir-modified magnetic separation material"],"prefix":"10.1007","author":[{"given":"Yini","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1690-578X","authenticated-orcid":false,"given":"Lingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"key":"238_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2002","unstructured":"N.L. Anderson, N.G. Anderson, The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteom. 1, 845\u2013867 (2002)","journal-title":"Mol. Cell. Proteom."},{"key":"238_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"N. Rifai, M.A. Gillette, S.A. Carr, Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24, 971\u2013983 (2006)","journal-title":"Nat. Biotechnol."},{"key":"238_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/35015709","volume":"405","author":"MM Akhilesh Pandey","year":"2000","unstructured":"M.M. Akhilesh Pandey, Proteomics to study genes and genomes. Nature 405, 837\u2013846 (2000)","journal-title":"Nature"},{"key":"238_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.cell.2008.08.012","volume":"134","author":"S Mahrus","year":"2008","unstructured":"S. Mahrus, J.C. Trinidad, D.T. Barkan, A. Sali, A.L. Burlingame, J.A. Wells, Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 134, 866\u2013876 (2008)","journal-title":"Cell"},{"key":"238_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1101\/gr.081901.108","volume":"19","author":"S Gallien","year":"2009","unstructured":"S. Gallien, E. Perrodou, C. Carapito, C. Deshayes, J.-M. Reyrat, A. Van Dorsselaer, O. Poch, C. Schaeffer, Lecompte, Ortho-proteogenomics: multiple proteomes investigation through orthology and a new MS-based protocol. Genome Res. 19, 128\u2013135 (2009)","journal-title":"Genome Res."},{"key":"238_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1021\/ac401000q","volume":"85","author":"J-S Kim","year":"2013","unstructured":"J.-S. Kim, Z. Dai, U.K. Aryal, R.J. Moore, D.G. Camp, S.E. Baker, R.D. Smith, W.-J. Qian, Resin-assisted enrichment of N-terminal peptides for characterizing proteolytic processing. Anal. Chem. 85, 7 (2013)","journal-title":"Anal. Chem."},{"key":"238_CR7","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1021\/pr070375k","volume":"6","author":"W Dormeyer","year":"2007","unstructured":"W. Dormeyer, S. Mohammed, B.V. Breukelen, J. Krijgsveld, A.J.R. Heck, Targeted analysis of protein termini. J. Proteome Res. 6, 4634\u20134645 (2007)","journal-title":"J. Proteome Res."},{"key":"238_CR8","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1021\/cb200164h","volume":"6","author":"G Xu","year":"2011","unstructured":"G. Xu, S.B.Y. Shin, S.R. Jaffrey, Chemoenzymatic labeling of protein C-termini for positive selection of C-terminal peptides. ACS Chem. Biol. 6, 1015\u20131020 (2011)","journal-title":"ACS Chem. Biol."},{"key":"238_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.trac.2021.116291","volume":"141","author":"HBR Eivazzadeh-Keihan","year":"2021","unstructured":"H.B.R. Eivazzadeh-Keihan, Z. Amiri et al., Functionalized magnetic nanoparticles for the separation and purification of proteins and peptides. Trends Anal. Chem. 141, 20 (2021)","journal-title":"Trends Anal. Chem."},{"key":"238_CR10","unstructured":"G.K. Sofer, L. Hagel, G.K. Sofer, et al. Handbook of process chromatography: a guide to optimization, scale up, and validation[J] (1997)"},{"key":"238_CR11","doi-asserted-by":"crossref","unstructured":"R.H. Davis, Theory for crossflow microfiltration (1992)","DOI":"10.1007\/978-1-4615-3548-5_33"},{"key":"238_CR12","unstructured":"S.L.M.L. Mir, V. Goel, R. Kaiser, Crossflow microfiltration: applications, design, and cost (1992)"},{"key":"238_CR13","unstructured":"Z.A.L. Zeman, Microfiltration and ultrafiltration: principles and applications (1996)"},{"key":"238_CR14","first-page":"8","volume":"150","author":"MBPF Garc\u00eda","year":"2015","unstructured":"M.B.P.F. Garc\u00eda, M. Wolf, S. Reinlein, M.F. von Roman, S. Berensmeier, High-gradient magnetic separation for technical scale protein recovery using low cost magnetic nanoparticles. Sep. Purif. 150, 8 (2015)","journal-title":"Sep. Purif."},{"key":"238_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41598-017-07516-x","volume":"7","author":"FGF Jiao","year":"2017","unstructured":"F.G.F. Jiao, H. Wang, Y. Deng, Y. Zhang, X. Qian, Y. Zhang, Polymeric hydrophilic ionic liquids used to modify magnetic nanoparticles for the highly selective enrichment of N-linked glycopeptides. Sci. Rep. 7, 11 (2017)","journal-title":"Sci. Rep."},{"key":"238_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.dmpk.2020.04.333","volume":"35","author":"T Wang","year":"2020","unstructured":"T. Wang, D. Babusis, Y. Park et al., Species differences in liver accumulation and metabolism of nucleotide prodrug sofosbuvir. Drug Metab. Pharmacokinet. 35, 7 (2020)","journal-title":"Drug Metab. Pharmacokinet."},{"key":"238_CR17","first-page":"15","volume":"8","author":"K Lipa","year":"2018","unstructured":"K. Lipa, M.J. Jab\u0142o\u0144ska, P. Kaczor et al., Sofosbuvir as a drug in recurrent HCV therapy occurring after liver transplantation. J. Educ. Health Sport 8, 15 (2018)","journal-title":"J. Educ. Health Sport"},{"key":"238_CR18","first-page":"1","volume":"10","author":"N Gupta","year":"2015","unstructured":"N. Gupta, R. Bodin et al., Autoimmune hepatitis in association with sofosbuvir. Am. J. Ther. 10, 1\u20133 (2015)","journal-title":"Am. J. Ther."},{"key":"238_CR19","unstructured":"W.S. Qin E, Cui Y, et al., A case of liver injury caused by DAA based therapy, Hepatol. Int. 11, S1043\u2013S1044 (2017)"},{"key":"238_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/cells9041003","volume":"9","author":"D Bojkova","year":"2020","unstructured":"D. Bojkova, S. Westhaus, R. Costa et al., Sofosbuvir activates EGFR-dependent pathways in hepatoma cells with implications for liver-related pathological processes. Cells 9, 18 (2020)","journal-title":"Cells"},{"key":"238_CR21","doi-asserted-by":"publisher","first-page":"12022","DOI":"10.3748\/wjg.v21.i42.12022","volume":"21","author":"FM Varshosaz","year":"2015","unstructured":"F.M. Varshosaz, Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World J. Gastroenterol. 21, 12022\u201312041 (2015)","journal-title":"World J. Gastroenterol."},{"key":"238_CR22","doi-asserted-by":"publisher","first-page":"14113","DOI":"10.1039\/C6CC07321B","volume":"52","author":"YA Li","year":"2016","unstructured":"Y.A. Li, X.D. Zhao, H.P. Yin, G.J. Chen, S. Yang, Y.B. Dong, A drug-loaded nanoscale metal-organic framework with a tumor targeting agent for highly effective hepatoma therapy. Chem. Commun. (Camb) 52, 14113\u201314116 (2016)","journal-title":"Chem. Commun. (Camb)"},{"key":"238_CR23","first-page":"285","volume":"12","author":"Z Li","year":"2017","unstructured":"Z. Li, W. Tao, D. Zhang, C. Wu, B. Song, S. Wang, T. Wang, M. Hu, X. Liu, Y. Wang, Y. Sun, J. Sun, The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration in vitro and in vivo, Asian. J. Pharm. Sci. 12, 285\u2013291 (2017)","journal-title":"J. Pharm. Sci."},{"key":"238_CR24","first-page":"10","volume":"143","author":"IUK Yasir Mehmooda","year":"2020","unstructured":"I.U.K. Yasir Mehmooda, Y. Shahzad et al., Amino-decorated mesoporous silica nanoparticles for controlled sofosbuvir delivery. Eur. J. Pharmaceut. Sci. 143, 10 (2020)","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"238_CR25","doi-asserted-by":"publisher","unstructured":"S.A. Loutfy, H.G. Abdelhady, M.H. Elberry, et al., In vitro evaluation of cytotoxic and anti-HCV-4 properties of sofosbuvir encapsulated chitosan nanoparticles (2020). https:\/\/doi.org\/10.48550\/arXiv.2009.06041[P]","DOI":"10.48550\/arXiv.2009.06041[P]"},{"key":"238_CR26","doi-asserted-by":"crossref","unstructured":"M.J.B. Sofia, D., Chang, W., Du, J., Nagarathnam, D. et al., Discovery of a \u03b2-d-2\u2032-deoxy-2\u2032-\u03b1-fluoro-2\u2032-\u03b2-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus, J. Med. Chem. 53, 7202\u20137218 (2010)","DOI":"10.1021\/jm100863x"},{"key":"238_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bmc.2019.01.005","volume":"27","author":"R Ovadia","year":"2019","unstructured":"R. Ovadia, A. Khalil, Hea Li, Synthesis and anti-HCV activity of \u03b2-D -20-deoxy-20-\u03b1-chloro-20-\u03b2-fluoro and \u03b2-d-20-deoxy-20-\u03b1-bromo-20-\u03b2-fluoro nucleosides and their phosphoramidate prodrugs. Bioorg. Med. Chem. 27, 13 (2019)","journal-title":"Bioorg. Med. Chem."},{"key":"238_CR28","first-page":"19","volume":"21","author":"BY Yanping Li","year":"2021","unstructured":"B.Y. Yanping Li, Y. Quan, Z. Li, Advancement of prodrug approaches for nucleotide antiviral agents. Curr. Topics Med. Chem. 21, 19 (2021)","journal-title":"Curr. Topics Med. Chem."},{"key":"238_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2021.338412","volume":"1158","author":"Y Pan","year":"2021","unstructured":"Y. Pan, C. Zhang, R. Xiao, L. Zhang, W. Zhang, Dual-functionalized magnetic bimetallic metal-organic framework composite for highly specific enrichments of phosphopeptides and glycopeptides. Anal. Chim. Acta 1158, 338412 (2021)","journal-title":"Anal. Chim. Acta"},{"issue":"Suppl 2","key":"238_CR30","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1186\/cc5161","volume":"11","author":"C Szab\u00f3","year":"2007","unstructured":"C. Szab\u00f3, G. Veres, T. Radovits, et al., Infusion of sodium sulfide improves myocardial and endothelial function in a canine model of cardiopulmonary bypass. Crit. Care 11 (Suppl 2), P1 (2007)","journal-title":"Crit. Care"},{"key":"238_CR31","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/MEG.0b013e3283293769","volume":"21","author":"OA Gressner","year":"2009","unstructured":"O.A. Gressner, C. Gao, M. Siluschek, P. Kim, A.M. Gressner, Inverse association between serum concentrations of actin-free vitamin D-binding protein and the histopathological extent of fibrogenic liver disease or hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol. 21, 990\u2013995 (2009)","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"6","key":"238_CR32","first-page":"445","volume":"18","author":"ZH Jiang","year":"2010","unstructured":"Z.H. Jiang, Z.Y. Zhang, M. He et al., The screening and identification of Apolipoprotein A-II from serum differential proteins in hepatocellular carcinoma patients. Chin. J. Hepatol. 18(6), 445\u2013449 (2010)","journal-title":"Chin. J. Hepatol."},{"key":"238_CR33","first-page":"5","volume":"7","author":"ZT Hui Jiang","year":"2013","unstructured":"Z.T. Hui Jiang, Pujun Gao, Xu. Yonghong, Xinjuan Kong, Han Zhang et al., Interaction of Beta2-glycoproteinI with lipopolysaccharide leads to NF-kappa B activation in hepatocellular carcinoma. Chin. J. Clin (Electronic Edition) 7, 5 (2013)","journal-title":"Chin. J. Clin (Electronic Edition)"},{"issue":"2","key":"238_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/JCMM.1000112","volume":"1","author":"VG Jonnalagadda","year":"2018","unstructured":"V.G. Jonnalagadda, K. Choudhary, V. Kranti Matety, Afamin, a novel biomarker: one for all concerns? J. Clin. Mol. Med. 1(2), 1\u20132 (2018)","journal-title":"J. Clin. Mol. Med."},{"key":"238_CR35","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.1007\/s12206-019-0931-8","volume":"33","author":"J-S Kim","year":"2019","unstructured":"J.-S. Kim, H.-J. Lee, Y.-J. Kim, Y.-B. Kim, The mesh density effect on stress intensity factor calculation using ABAQUS XFEM. J. Mech. Sci. Technol. 33, 4909\u20134916 (2019)","journal-title":"J. Mech. Sci. Technol."},{"key":"238_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238251","volume":"15","author":"TT Chang","year":"2020","unstructured":"T.T. Chang, C.H. Ho, Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma. PLoS ONE 15, e0238251 (2020)","journal-title":"PLoS ONE"},{"key":"238_CR37","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41419-020-03030-7","volume":"11","author":"T Chen","year":"2020","unstructured":"T. Chen, X. Dai, J. Dai, C. Ding, Z. Zhang, Z. Lin, J. Hu, M. Lu, Z. Wang, Y. Qi, L. Zhang, R. Pan, Z. Zhao, L. Lu, W. Liao, X. Lu, AFP promotes HCC progression by suppressing the HuR-mediated Fas\/FADD apoptotic pathway. Cell Death Dis. 11, 822 (2020)","journal-title":"Cell Death Dis."},{"key":"238_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117911","volume":"256","author":"N Fu","year":"2020","unstructured":"N. Fu, H. Du, D. Li, Y. Lu, W. Li, Y. Wang, L. Kong, J. Du, S. Zhao, W. Ren, F. Han, R. Wang, Y. Zhang, Y. Nan, Clusterin contributes to hepatitis C virus-related hepatocellular carcinoma by regulating autophagy. Life Sci. 256, 117911 (2020)","journal-title":"Life Sci."},{"key":"238_CR39","first-page":"5","volume":"31","author":"WL Jianwen Zhang","year":"2020","unstructured":"W.L. Jianwen Zhang, B. Fu, K. Hu, S. Liu, H. Li, Q. Zhang, M. Li, G. Chen, Proteomic screening of serum hepatocellular carcinoma-associated proteins by an acetonitrile-pretreatment method. J. Sun Yan-Sen Univ. (Med. Sci.) 31, 5 (2020)","journal-title":"J. Sun Yan-Sen Univ. (Med. Sci.)"},{"key":"238_CR40","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s12029-020-00486-w","volume":"51","author":"F Ozdemir","year":"2020","unstructured":"F. Ozdemir, A. Baskiran, The importance of AFP in liver transplantation for HCC. J. Gastrointest. Cancer 51, 1127\u20131132 (2020)","journal-title":"J. Gastrointest. Cancer"},{"key":"238_CR41","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8301","volume":"8","author":"F Xue","year":"2020","unstructured":"F. Xue, L. Yang, B. Dai, H. Xue, L. Zhang, R. Ge, Y. Sun, Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma. PeerJ 8, e8301 (2020)","journal-title":"PeerJ"},{"key":"238_CR42","first-page":"24","volume":"13","author":"TM Qing-hua Chang","year":"2021","unstructured":"T.M. Qing-hua Chang, Y. Tao, T. Dong, Xx. Tang, G.-h Ge, Zj. Xu, Pan-cancer analysis identifies ITIH1 as a novel prognostic indicator for hepatocellular carcinoma. Aging 13, 24 (2021)","journal-title":"Aging"},{"key":"238_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.imlet.2021.05.007","volume":"236","author":"LE Santiesteban-Lores","year":"2021","unstructured":"L.E. Santiesteban-Lores, M.C. Carneiro, L. Isaac, L. Bavia, Complement system in alcohol-associated liver disease. Immunol. Lett. 236, 37\u201350 (2021)","journal-title":"Immunol. Lett."},{"key":"238_CR44","first-page":"3","volume":"17","author":"YL Liya Mu","year":"1988","unstructured":"Y.L. Liya Mu, C. Wang, X. Zhang, Diagnostic value of combined \u03b11-antitrypsin, \u03b11-acid glycoprotein and prealbumin assay for hepatocellular carcinoma. Shanxi Med. J. 17, 3 (1988)","journal-title":"Shanxi Med. J."},{"key":"238_CR45","first-page":"9","volume":"61","author":"AT-CC Terence Chuen-Wai Poon","year":"2001","unstructured":"A.T.-C.C. Terence Chuen-Wai Poon, B. Zee, S. King-Wah Ho, T. Shu-Kam Mok, T. Wai-Tong Leung, P. James Johnson, Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma. Oncology 61, 9 (2001)","journal-title":"Oncology"},{"key":"238_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/ijc.20986","volume":"116","author":"T Utsunomiya","year":"2005","unstructured":"T. Utsunomiya, K. Ogawa, K. Yoshinaga, M. Ohta, K. Yamashita, K. Mimori, H. Inoue, T. Ezaki, Y. Yoshikawa, M. Mori, Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma. Int. J. Cancer 116, 105\u2013109 (2005)","journal-title":"Int. J. Cancer"},{"key":"238_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jim.2005.10.010","volume":"308","author":"EY Lee","year":"2006","unstructured":"E.Y. Lee, J.H. Kang, K.A. Kim, T.W. Chung, H.J. Kim, D.Y. Yoon, H.G. Lee, D.H. Kwon, J.W. Kim, C.H. Kim, E.Y. Song, Development of a rapid, immunochromatographic strip test for serum asialo alpha1-acid glycoprotein in patients with hepatic disease. J. Immunol. Methods 308, 116\u2013123 (2006)","journal-title":"J. Immunol. Methods"},{"key":"238_CR48","first-page":"4","volume":"18","author":"XX Hongguang Han","year":"2009","unstructured":"X.X. Hongguang Han, J. Zhang, Expression and significance of angiotensin II and angiotensin II type I receptor in human hepatocellular carcinoma. Chin. J. General Surg. 18, 4 (2009)","journal-title":"Chin. J. General Surg."},{"key":"238_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jprot.2016.09.004","volume":"153","author":"P Darebna","year":"2017","unstructured":"P. Darebna, P. Novak, R. Kucera, O. Topolcan, M. Sanda, R. Goldman, P. Pompach, Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring. J. Proteom. 153, 44\u201352 (2017)","journal-title":"J. Proteom."},{"key":"238_CR50","first-page":"6","volume":"32","author":"WY Xianlin Zhan","year":"2017","unstructured":"W.Y. Xianlin Zhan, C. Gao, Research progress on alpha-2-macroglobulin and its glycosylation in tumor. Lab. Med. 32, 6 (2017)","journal-title":"Lab. Med."},{"key":"238_CR51","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1096\/fj.201700941RR","volume":"32","author":"G Aran","year":"2018","unstructured":"G. Aran, L. Sanjurjo, C. Barcena, M. Simon-Coma, E. Tellez, M. Vazquez-Vitali, M. Garrido, L. Guerra, E. Diaz, I. Ojanguren, F. Elortza, R. Planas, M. Sala, C. Armengol, M.R. Sarrias, CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78). FASEB J. 32, 3878\u20133891 (2018)","journal-title":"FASEB J."},{"key":"238_CR52","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ebiom.2019.04.052","volume":"43","author":"C Barcena","year":"2019","unstructured":"C. Barcena, G. Aran, L. Perea, L. Sanjurjo, E. Tellez, A. Oncins, H. Masnou, I. Serra, M. Garcia-Gallo, L. Kremer, M. Sala, C. Armengol, P. Sancho-Bru, M.R. Sarrias, CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content. EBioMedicine 43, 513\u2013524 (2019)","journal-title":"EBioMedicine"},{"key":"238_CR53","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.clinre.2019.12.010","volume":"44","author":"V Peta","year":"2020","unstructured":"V. Peta, J. Zhu, D.M. Lubman, S. Huguet, F. Imbert-Bismutd, G. Bolbach, G. Clodic, L. Matheron, Y. Ngo, P. Raluca, C. Housset, K. Rezai, T. Poynard, G. FibroFrance-Groupe Hospitalier Pitie Salpetriere, Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease. Clin. Res. Hepatol. Gastroenterol. 44, 681\u2013691 (2020)","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"238_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109633","volume":"72","author":"Y Shang","year":"2020","unstructured":"Y. Shang, M. Luo, F. Yao, S. Wang, Z. Yuan, Y. Yang, Ceruloplasmin suppresses ferroptosis by regulating iron homeostasis in hepatocellular carcinoma cells. Cell Signal 72, 109633 (2020)","journal-title":"Cell Signal"},{"key":"238_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111868","volume":"141","author":"HF Zhang","year":"2021","unstructured":"H.F. Zhang, X. Gao, X. Wang, X. Chen, Y. Huang, L. Wang, Z.W. Xu, The mechanisms of renin-angiotensin system in hepatocellular carcinoma: from the perspective of liver fibrosis HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures. Biomed. Pharmacother. 141, 111868 (2021)","journal-title":"Biomed. Pharmacother."},{"key":"238_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2021.02.124","volume":"555","author":"D Li","year":"2021","unstructured":"D. Li, P. Xie, S. Zhao et al., Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD. Biochem. Biophys. Res. Commun. 555, 7 (2021)","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Analytical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44211-022-00238-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44211-022-00238-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44211-022-00238-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T20:03:21Z","timestamp":1672085001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44211-022-00238-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":56,"alternative-id":["238"],"URL":"https:\/\/doi.org\/10.1007\/s44211-022-00238-9","relation":{},"ISSN":["0910-6340","1348-2246"],"issn-type":[{"type":"print","value":"0910-6340"},{"type":"electronic","value":"1348-2246"}],"subject":[],"published":{"date-parts":[[2022,12,26]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of Zhongshan Hospital Fudan University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}